SALT试验:激光小梁成形术后使用类固醇——短期抗炎治疗对选择性激光小梁成形术疗效的影响
这项双盲随机安慰剂对照双中心多术者试验纳入96眼(85例),比较SLT术后短期使用酮咯酸0.5%、泼尼松龙1%或生理盐水滴眼液对眼压的影响。结果显示术后12周非甾体抗炎药组和类固醇组眼压下降均显著大于安慰剂组,短期术后使用可能改善SLT后眼压下降,需更长期随访研究。
要点
- SLT术后12周,非甾体抗炎药组和类固醇组眼压下降均显著大于安慰剂组。
- 术后6周时三组眼压下降无统计学显著差异。
- 术后短期使用非甾体抗炎药或类固醇滴眼液可能改善SLT后眼压下降。
核心结论
- SLT术后12周,使用类固醇或非甾体抗炎药滴眼液的眼压下降显著更优。
- SLT术后短期使用非甾体抗炎药或类固醇滴眼液可能改善眼压下降。
- 需要更长期的随访研究。
研究设计与样本
- 双盲、随机、安慰剂对照、双中心、多术者试验。
- 纳入96眼(85例)年龄大于18岁、眼压大于18 mmHg且临床决定SLT为适当指示治疗的患者。
- 按1:1:1随机分为酮咯酸0.5%、泼尼松龙1%或生理盐水泪液三组。
- SLT术后当日开始使用无标记滴眼液,每日4次,连续额外4天。
主要发现
- 非甾体抗炎药组、类固醇组和安慰剂组基线人口学特征和基线眼压相似(均值23.3±3.9 mmHg;P=0.57)。
- 术后6周时三组眼压下降无统计学显著差异。
- 术后12周非甾体抗炎药组眼压下降-6.2±3.1 mmHg,类固醇组-5.2±2.7 mmHg,安慰剂组-3±4.3 mmHg。
- 非甾体抗炎药组 vs 安慰剂组:方差分析P=0.02,t检验P=0.002;类固醇组 vs 安慰剂组:P=0.02。
局限性
- 需要更长期的随访研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study examined whether short-term use of topical nonsteroidal anti-inflammatory drug (NSAID) or steroid therapy affected the efficacy of selective laser trabeculoplasty (SLT). DESIGN: Double-masked, randomized, placebo-controlled, dual-center, multisurgeon trial. PARTICIPANTS: Patients older than 18 years with intraocular pressure (IOP) of more than 18 mmHg for whom the clinician decided SLT was the appropriately indicated therapy were randomized to 1 of 3 groups in a ratio of 1:1:1 as follows: ketorolac 0.5%, prednisolone 1%, or saline tears. METHODS: After SLT, patients randomized into each group were instructed to use an unmarked drop 4 times daily starting the day of SLT and continuing for 4 additional days. The Kruskal-Wallis test and Wilcoxon rank-sum test were used for continuous variables when comparing 2 or 3 treatment groups, respectively. The Fisher exact test was used for categorical variables. MAIN OUTCOME MEASURES: The primary outcome of this study was IOP at 12 weeks. Secondary outcome measures included IOP at 1 and 6 weeks, patient-reported pain, and detectable anterior chamber inflammation. RESULTS: Ninety-six eyes of 85 patients fit inclusion criteria and were enrolled between the 2 sites. The NSAID, steroid, and placebo groups were similar in baseline demographics and baseline IOP (mean, 23.3±3.9 mmHg; P = 0.57). There was no statistically significant difference in IOP decrease among groups at week 6. Both the NSAID and steroid groups showed a statistically significantly greater decrease in IOP at week 12 compared with the placebo group (mean, -6.2±3.1 mmHg, -5.2±2.7 mmHg, and -3±4.3 mmHg, respectively; P = 0.02 [analysis of variance] and P = 0.002 [t test] for NSAID vs. placebo groups; P = 0.02 for steroid vs. placebo groups). CONCLUSIONS: Significantly better IOP reduction at 12 weeks was measured in eyes treated with steroid or NSAID drops after SLT. Short-term postoperative use of NSAID or steroid drops may improve IOP reduction after SLT. Longer-term follow-up studies are indicated.
引用
- Groth SL, Albeiruti E, Nunez M, et al. SALT Trial: Steroids after Laser Trabeculoplasty: Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy. Ophthalmology. 2019. PMID: 31444008. doi:10.1016/j.ophtha.2019.05.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。